27 July 2026
No UK prescriber, whether doctor, dentist, pharmacist or nurse, can lawfully prescribe Botox or another injectable cosmetic medicine after only a video call or phone consultation. The General Medical Council, General Dental Council, General Pharmaceutical Council and Nursing and Midwifery Council all require a face-to-face assessment before the prescription is written, and each regulator treats a breach as a fitness-to-practise matter. The rule has tightened steadily since the GMC's original ban in 2012, and the NMC's own update took effect on 1 June 2025. For practitioners building virtual consultation models, knowing exactly where the video call must stop and the in-person visit must begin is essential.
The GMC's rule for doctors
The GMC's guidance, Good practice in prescribing and managing medicines and devices, in force since 5 April 2021 and updated on 15 March 2022, states that doctors must carry out a physical examination before prescribing injectable cosmetic medicines such as Botox, Dysport or Vistabel. The GMC's FAQs on cosmetic interventions are explicit: these medicines must not be prescribed by telephone, video link, online, or at the request of a third party for a patient the doctor has not examined. The position traces back to a widely reported 2012 fitness-to-practise case that first prompted the ban on remote prescribing in cosmetic medicine. Breaching it is treated as a serious departure from Good Medical Practice, not a technicality.
GDC and GPhC: the same standard for dentists and pharmacist prescribers
The General Dental Council has held since 2011 that remote prescribing must not be used for non-surgical cosmetic procedures such as Botox, meaning a dentist prescribing for a patient must have examined them in person first. The General Pharmaceutical Council updated its position in April 2025 to state that a prescription for these medicines should only follow a physical examination, and that a remote consultation is not appropriate for this purpose. Both regulators also limit delegation: administration can only be handed to another practitioner who is properly trained, and where the product is prescription-only, the prescriber's own in-person assessment is still required.
The NMC's June 2025 update for nurse and midwife prescribers
The Nursing and Midwifery Council published updated guidance on 29 April 2025, confirming that independent nurse and midwife prescribers must carry out a face-to-face consultation before prescribing non-surgical cosmetic medicines, including anti-wrinkle injections and items commonly held in an aesthetic emergency kit such as hyaluronidase. The change took effect on 1 June 2025. The NMC said the update reflected public concern that patients were often unaware their treatment involved a prescribed medicine at all, and was intended to bring nursing prescribers into line with the other health and care regulators.
What this means for clinics running virtual consultations
None of the four regulators bans video calls outright, screening, triage, follow-up reviews and aftercare check-ins can still happen remotely. What cannot happen remotely is the assessment that leads directly to the prescribing decision itself: that step needs the prescriber in the same room as the patient. Clinics marketing a fully remote or fly-in model should treat this as a hard boundary rather than a grey area, particularly as the wider direction of travel, including the government's proposed licensing scheme for non-surgical procedures, continues to raise the bar on documented, in-person clinical accountability.
Common questions
- Can a nurse prescriber assess a patient over video before Botox?
- No. Since 1 June 2025, NMC guidance requires nurse and midwife prescribers to carry out a face-to-face consultation before prescribing non-surgical cosmetic medicines, including anti-wrinkle injections.
- What happens if a practitioner prescribes cosmetic injectables remotely?
- It is treated as a fitness-to-practise issue by the relevant regulator, GMC, GDC, GPhC or NMC, and can put registration at risk, regardless of how the consultation was conducted or documented.
- Does the face-to-face rule apply to dermal fillers as well as Botox?
- Dermal fillers themselves are not prescription-only medicines, but related prescribing, such as hyaluronidase used to dissolve filler in an emergency, is covered by the same in-person requirement.
Where Sulaia helps
The practitioner workspace
One calendar, one home, across every clinic you visit.
See how it works